Open EC Technologies announces sales revenue for first fiscal quarter

Open EC Technologies, Inc. ("Open EC" or the "Company") (TSX VENTURE:OCE) announced today sales revenue for the first fiscal quarter $293,287 with EBITDA from continuing operations of $7,613.

Highlights of the performance during the three months ended September 30, 2009 are as follows:

The revenues for the quarter were $293,257 with an EBITDA from continuing operations of $7,613 as compared with revenues of $209,511 and an EBITDA from continuing operations of ($122,967) during the same period in the last fiscal year. 

The comparative financial statements for the three months ended September 30, 2009, along with other information, may be obtained through the Company's website at www.openec.com or on SEDAR at www.sedar.com

The Company announces that subject to regulatory acceptance it will settle $28,000 in debt by the issuance of 280,000 shares at $0.10 per share.

Subject to TSX Venture Exchange acceptance, a company, controlled by a director, has agreed to settle debt totaling $28,000 by taking common shares. The settlement is made with a company controlled by Michael Chen, CFO and director of the Company.

The Company is settling the debt by issuing shares in order to preserve its cash for working capital and future growth.

http://www.openec.com/

Posted in:

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.